119 related articles for article (PubMed ID: 38258347)
1. Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs.
Xu J; Yu SJ; Sun S; Li YP; Zhang X; Jin K; Jin ZB
Glia; 2024 May; 72(5):872-884. PubMed ID: 38258347
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
Vincent A; Krishnakumar S; Parameswaran S
Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
[TBL] [Abstract][Full Text] [Related]
3. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
4. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
Rozanska A; Cerna-Chavez R; Queen R; Collin J; Zerti D; Dorgau B; Beh CS; Davey T; Coxhead J; Hussain R; Al-Aama J; Steel DH; Benvenisty N; Armstrong L; Parulekar M; Lako M
Stem Cells Transl Med; 2022 Apr; 11(4):415-433. PubMed ID: 35325233
[TBL] [Abstract][Full Text] [Related]
5. Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory.
Li YP; Wang YT; Wang W; Zhang X; Shen RJ; Jin K; Jin LW; Jin ZB
PNAS Nexus; 2022 Sep; 1(4):pgac162. PubMed ID: 36714839
[TBL] [Abstract][Full Text] [Related]
6. Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma.
Balaji S; Rao A; Saraswathi KK; Sethu Nagarajan R; Santhi R; Kim U; Muthukkaruppan V; Vanniarajan A
Med Oncol; 2024 Jun; 41(7):168. PubMed ID: 38834895
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
8.
Kanber D; Woestefeld J; Döpper H; Bozet M; Brenzel A; Altmüller J; Kilpert F; Lohmann D; Pommerenke C; Steenpass L
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565295
[TBL] [Abstract][Full Text] [Related]
9. RB116: an RB1+ retinoblastoma cell line expressing primitive markers.
Bejjani A; Choi MR; Cassidy L; Collins DW; O'Brien JM; Murray T; Ksander BR; Seigel GM
Mol Vis; 2012; 18():2805-13. PubMed ID: 23233783
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
[TBL] [Abstract][Full Text] [Related]
11. Compensation by tumor suppressor genes during retinal development in mice and humans.
Donovan SL; Schweers B; Martins R; Johnson D; Dyer MA
BMC Biol; 2006 May; 4():14. PubMed ID: 16672052
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin.
Liu H; Zhang Y; Zhang YY; Li YP; Hua ZQ; Zhang CJ; Wu KC; Yu F; Zhang Y; Su J; Jin ZB
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33628-33638. PubMed ID: 33318192
[TBL] [Abstract][Full Text] [Related]
13. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.
Karlstetter M; Nothdurfter C; Aslanidis A; Moeller K; Horn F; Scholz R; Neumann H; Weber BH; Rupprecht R; Langmann T
J Neuroinflammation; 2014 Jan; 11():3. PubMed ID: 24397957
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma from human stem cell-derived retinal organoids.
Norrie JL; Nityanandam A; Lai K; Chen X; Wilson M; Stewart E; Griffiths L; Jin H; Wu G; Orr B; Tran Q; Allen S; Reilly C; Zhou X; Zhang J; Newman K; Johnson D; Brennan R; Dyer MA
Nat Commun; 2021 Jul; 12(1):4535. PubMed ID: 34315877
[TBL] [Abstract][Full Text] [Related]
15. miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway.
Gao Y; Du P
Mol Biotechnol; 2024 Jan; 66(1):102-111. PubMed ID: 37041423
[TBL] [Abstract][Full Text] [Related]
16. Functional microglia derived from human pluripotent stem cells empower retinal organ.
Gao ML; Zhang X; Han F; Xu J; Yu SJ; Jin K; Jin ZB
Sci China Life Sci; 2022 Jun; 65(6):1057-1071. PubMed ID: 35451725
[TBL] [Abstract][Full Text] [Related]
17. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
[TBL] [Abstract][Full Text] [Related]
18. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
Avior Y; Lezmi E; Yanuka D; Benvenisty N
Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
[TBL] [Abstract][Full Text] [Related]
19. Integrating human iPSC-derived macrophage progenitors into retinal organoids to generate a mature retinal microglial niche.
Usui-Ouchi A; Giles S; Harkins-Perry S; Mills EA; Bonelli R; Wei G; Ouchi Y; Ebihara N; Nakao S; Friedlander M; Eade KT
Glia; 2023 Oct; 71(10):2372-2382. PubMed ID: 37335016
[TBL] [Abstract][Full Text] [Related]
20. Synergic effects of EP2 and FP receptors co-activation on Blood-Retinal Barrier and Microglia.
Nakamura N; Honjo M; Yamagishi R; Sakata R; Watanabe S; Aihara M
Exp Eye Res; 2023 Dec; 237():109691. PubMed ID: 37884204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
